Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies

International Journal of Molecular Sciences

Giuseppe Ciconte¹  Marco Piccoli¹  Federica Cirillo¹  MichelleM. Monasky¹  Carlo Pappone¹  Andrea Ghiroldi¹  Luigi Anastasia¹ 

[1] IRCCS Policlinico San Donato, Piazza Malan 2, San Donato Milanese, 20097 Milan, Italy;

关键词: heart dysfunction;    heart failure;    cardiac regeneration;    stem cells;    cell therapy;    cardiac clinical trials;    translational medicine;   

DOI  :  10.3390/ijms19103194

来源: DOAJ

【 摘 要 】

Despite considerable improvements in the treatment of cardiovascular diseases, heart failure (HF) still represents one of the leading causes of death worldwide. Poor prognosis is mostly due to the limited regenerative capacity of the adult human heart, which ultimately leads to left ventricular dysfunction. As a consequence, heart transplantation is virtually the only alternative for many patients. Therefore, novel regenerative approaches are extremely needed, and several attempts have been performed to improve HF patients’ clinical conditions by promoting the replacement of the lost cardiomyocytes and by activating cardiac repair. In particular, cell-based therapies have been shown to possess a great potential for cardiac regeneration. Different cell types have been extensively tested in clinical trials, demonstrating consistent safety results. However, heterogeneous efficacy data have been reported, probably because precise end-points still need to be clearly defined. Moreover, the principal mechanism responsible for these beneficial effects seems to be the paracrine release of antiapoptotic and immunomodulatory molecules from the injected cells. This review covers past and state-of-the-art strategies in cell-based heart regeneration, highlighting the advantages, challenges, and limitations of each approach.

【 授权许可】

Unknown